Yiping Yang, MD, PhD

Yiping Yang

College

College of Medicine

Department/Division

Internal Medicine

Academic Title

Professor

Research Program

Leukemia Research

Leadership Title

Director, Division of Hematology

Yiping Yang, MD, PhD, is a nationally recognized expert in cancer immunology and immunotherapy who serves as the director of the Division of Hematology at The Ohio State University. He is also a member of the Leukemia Research Program at the OSUCCC – James, where he specializes in the treatment of lymphoma, leukemia and virus-associated malignancies.

Dr. Yang’s research interests focus on tumor immunology and viral immunity, with the ultimate goal of developing effective immunotherapy approaches for treating cancer. Current projects include investigating novel NK and T cell-mediated strategies for cancer immunotherapy with stem cell transplant, understanding mechanisms for the generation of long-lived tumor-specific memory T cells, and numerous studies focused on enhancing scientific understanding of the elements of the tumor microenvironment in cancer development and progression.

Additionally, Dr. Yang will be an important collaborator in the new Pelotonia Institute for Immuno-Oncology (PIIO), a comprehensive bench-to-bedside research initiative at the OSUCCC – James launched in July 2019 under the leadership of Zihai Li, PhD. The PIIO is focused on harnessing the body’s immune system to fight cancer at all levels – from prevention to treatment and survivorship.

Dr. Yang’s work has generated more than 100 peer-reviewed manuscripts published in leading scientific journals and has culminated in multiple current principal investigator R01 grants from the National Institutes of Health. He is an elected member of the American Society for Clinical Investigation and a fellow of the Alliance for Cancer Gene Therapy. He has also assumed numerous national leadership roles related to research and education, including serving on the National Institutes of Health’s Immune Mechanisms of Viral Control Program committee, as well as the American Society of Gene and Cell Therapy’s Immunology of Gene & Cell Therapy and Cancer Gene & Cell Therapy committees. A recognized leader in the field of immune mechanisms, he is a past associate editor of the Journal of Clinical Investigation and current associate editor of the Journal of Clinical Investigation Insight.


Education

  • Doctorate, University of Michigan

    Ann Arbor, MI (USA)

  • Doctorate, Zheijiang University School of Medicine

    Hangzhou, Zhejiang (China)

  • Doctorate, University of Michigan

    Ann Arbor, MI (USA)

  • Doctorate, Zheijiang University School of Medicine

    Hangzhou, Zhejiang (China)

Office Location

508 BRT

460 W 12th Ave, Columbus, OH 43210




Back to Researcher Search

Please enter a keyword (i.e. Name, Research Interest) or choose a Research Program

OR

Please enter a keyword (i.e. Name, Cancer Type) or choose a Principle Investigator

OR

Search for Clinical Trials

Find a Scientific Publication